New PKU nighttime treatment tested for better blood control
NCT ID NCT05487378
Summary
This study tested if a new protein substitute called PKU GOLIKE, taken at night, helps keep blood phenylalanine levels more stable in children with PKU compared to their standard amino acid treatment. Sixteen children tried both treatments for one week each, with a break in between. Researchers measured blood levels overnight and collected other health information to see if the new product worked better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Birmingham Children's Hospital Steelhouse Lane
Birmingham, B4 6NH, United Kingdom
Conditions
Explore the condition pages connected to this study.